Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

APARNA TAMIRISA

Allopathic & Osteopathic Physicians Internal Medicine

NPI
1124273974
CMS profile
6084
Location
SUGAR LAND, TX

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2022 · Entire year

$964.56

53 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2022 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $964.56 53

By paying entity

PY2022 · entire year · sorted by reported total

Page 1 of 2; records 1–50 of 53 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

APARNA TAMIRISA

NPI 1124273974 · CMS profile ID 6084

Allopathic & Osteopathic Physicians / Internal Medicine

SUGAR LAND, TX

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 1 of 2; records 1–50 of 53 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1124273974?year=2022&recipient=provider#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
APARNA TAMIRISA, NPI 1124273974, CMS profile ID 6084. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 2; records 1–50 of 53 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1124273974?year=2022&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
APA 7
IndustryPayments. (2026). APARNA TAMIRISA, NPI 1124273974, CMS profile ID 6084. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 2; records 1–50 of 53 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1124273974?year=2022&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
Bluebook
APARNA TAMIRISA, NPI 1124273974, CMS profile ID 6084, IndustryPayments, General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 1 of 2; records 1–50 of 53 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c. https://industrypayments.org/provider/npi-1124273974?year=2022&recipient=provider#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2022

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2022 · Physicians and non-physician practitioners · CMS publication 2026-06-30

53 matching records · $964.56 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 53 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–50 of 53.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
OptiNose US, Inc. $16.6412/12/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 928124337 CMS
Amgen Inc. $17.9111/21/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 939880957 CMS
ABBVIE INC. $16.9011/18/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 892491545 CMS
Bayer HealthCare Pharmaceuticals Inc. $1.8611/14/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 929867715 CMS
Bayer HealthCare Pharmaceuticals Inc. $16.0611/14/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 929969943 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $21.4710/27/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 887391831 CMS
Novo Nordisk Inc $16.2110/24/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 898588941 CMS
ABBVIE INC. $17.9910/07/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 892491543 CMS
Bayer HealthCare Pharmaceuticals Inc. $2.6710/05/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 929862725 CMS
Bayer HealthCare Pharmaceuticals Inc. $16.7410/05/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 930194683 CMS
Amgen Inc. $11.8709/26/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 939294317 CMS
Lilly USA, LLC $15.9509/19/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 917882139 CMS
Lilly USA, LLC $12.2009/06/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 917884877 CMS
OptiNose US, Inc. $24.0909/01/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 928124255 CMS
ABBVIE INC. $22.5608/26/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 892491541 CMS
Amgen Inc. $11.8208/08/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 939294315 CMS
Bayer HealthCare Pharmaceuticals Inc. $23.9108/03/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 930173019 CMS
Lilly USA, LLC $22.8108/02/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 917883079 CMS
ABBVIE INC. $28.1707/29/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 892491539 CMS
AstraZeneca Pharmaceuticals LP $12.3607/27/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 915269755 CMS
Amgen Inc. $20.1107/19/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 939880955 CMS
Bayer HealthCare Pharmaceuticals Inc. $32.1406/24/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 930108663 CMS
Amgen Inc. $11.6506/20/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 939294313 CMS
Novartis Pharmaceuticals Corporation $14.1305/19/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 894411047 CMS
Novo Nordisk Inc $18.0605/16/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 899009635 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $25.9805/12/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 887353305 CMS
Kowa Pharmaceuticals America, Inc. $16.4905/10/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 900399147 CMS
OptiNose US, Inc. $22.9005/03/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 928124193 CMS
Amgen Inc. $12.0505/02/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 939294311 CMS
Esperion Therapeutics, Inc. $20.0804/29/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 947286681 CMS
OptiNose US, Inc. $7.4704/22/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 928124197 CMS
AstraZeneca Pharmaceuticals LP $14.2504/19/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 915630303 CMS
GlaxoSmithKline, LLC. $17.2904/18/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 944609893 CMS
Bayer HealthCare Pharmaceuticals Inc. $26.8204/12/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 930284265 CMS
Amgen Inc. $20.6304/08/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 939880953 CMS
Novo Nordisk Inc $12.4203/31/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 899422517 CMS
OptiNose US, Inc. $23.2503/28/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 928124169 CMS
Bayer HealthCare Pharmaceuticals Inc. $24.1803/09/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 930146311 CMS
Abbott Laboratories $24.5603/08/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 914142143 CMS
OptiNose US, Inc. $27.6803/02/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 928124129 CMS
Amgen Inc. $22.1602/24/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 939880951 CMS
Novo Nordisk Inc $13.9002/23/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 899422079 CMS
Janssen Pharmaceuticals, Inc $20.7202/17/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 886950945 CMS
OptiNose US, Inc. $20.2902/08/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 928124125 CMS
Novartis Pharmaceuticals Corporation $17.2802/07/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 894411045 CMS
Bayer HealthCare Pharmaceuticals Inc. $23.9402/01/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 930056873 CMS
Novo Nordisk Inc $13.9801/31/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 898863359 CMS
Amarin Pharma Inc. $21.7301/28/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 913947435 CMS
Kowa Pharmaceuticals America, Inc. $17.8201/27/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 900380677 CMS
Medtronic, Inc. $18.8201/25/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 930456489 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $82.95 5
PY2020 $241.91 14
PY2021 $436.11 29
PY2022 $964.56 53
PY2023 $844.80 53
PY2024 $738.71 36
PY2025 $1,000.48 51

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $417,693.13 33
PY2024 Principal investigator $337,941.60 29
PY2023 Principal investigator $114,419.07 43
PY2022 Principal investigator $112,985.59 129
PY2021 Principal investigator $135,746.11 40
PY2020 Principal investigator $314,454.61 68
PY2019 Principal investigator $340,052.76 93

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2022

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

129 records in PY2022

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Acrotech Biopharma LLC $2,384.10 12/29/2022 Non-covered Recipient Entity
HOUSTON CENTER FOR CLINICAL RESEARCH
246-13651-301 No dispute reported 06/30/2026 941419451
Principal investigator 1 Novo Nordisk AS $619.32 12/21/2022 Non-covered Recipient Entity
HOUSTON CENTER FOR CLINICAL RESEARCH
EX9536-4388 No dispute reported 06/30/2026 896853699
Principal investigator 1 ABBVIE INC. $5,006.73 12/08/2022 Non-covered Recipient Entity
HOUSTON CENTER FOR CLINICAL RESEARC
Long-Term Safety Study of Elagolix in Combination With Estradiolx2FNorethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women No dispute reported 06/30/2026 890369955
Principal investigator 1 E.R. Squibb & Sons, L.L.C. $17,409.11 11/04/2022 Non-covered Recipient Entity
Houston Center For Clinical Research
Long-Term Study That Measures the Safety and Efficacy of BMS-986165 in Participants With Psoriasis No dispute reported 06/30/2026 933188445
Principal investigator 1 Myovant Sciences Inc. $3,782.05 10/25/2022 Non-covered Recipient Entity
HOUSTON CTR FOR CLINICAL RESEARCH
SPIRIT EXTENSION AN INTERNATIONAL PHASE 3 OPEN-LABEL, SINGLE-ARM, SAFETY AND EFFICACY EXTENSION STUDY TO EVALUATE RELUGOLIX ADMINISTERED WITH LOW-DOSE ESTRADIOL AND NORETHINDRONE ACETATE IN WOMEN WITH ENDOMETRIOSIS-ASSOCIATED PAIN No dispute reported 06/30/2026 941280449
Principal investigator 1 Novo Nordisk AS $1,238.63 10/21/2022 Non-covered Recipient Entity
HOUSTON CENTER FOR CLINICAL RESEARCH
EX9536-4388 No dispute reported 06/30/2026 896987061
Principal investigator 1 ABBVIE INC. $29,913.83 10/13/2022 Non-covered Recipient Entity
HOUSTON CENTER FOR CLINICAL RESEARC
Long-Term Safety Study of Elagolix in Combination With Estradiolx2FNorethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women No dispute reported 06/30/2026 890368969
Principal investigator 1 Novo Nordisk AS $1,850.63 09/30/2022 Non-covered Recipient Entity
HOUSTON CENTER FOR CLINICAL RESEARCH
EX9536-4388 No dispute reported 06/30/2026 896987057
Principal investigator 1 ABBVIE INC. $6,910.26 09/07/2022 Non-covered Recipient Entity
HOUSTON CENTER FOR CLINICAL RESEARC
Long-Term Safety Study of Elagolix in Combination With Estradiolx2FNorethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women No dispute reported 06/30/2026 890365789
Principal investigator 1 Novo Nordisk AS $495.00 08/26/2022 Non-covered Recipient Entity
HOUSTON CENTER FOR CLINICAL RESEARCH
EX9536-4388 No dispute reported 06/30/2026 896927863
Principal investigator 1 ABBVIE INC. $2,474.60 08/11/2022 Non-covered Recipient Entity
HOUSTON CENTER FOR CLINICAL RESEARC
Long-Term Safety Study of Elagolix in Combination With Estradiolx2FNorethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women No dispute reported 06/30/2026 890365787
Principal investigator 1 Novo Nordisk AS $22.76 08/11/2022 Non-covered Recipient Entity
HOUSTON CENTER FOR CLINICAL RESEARCH
EX9536-4388 No dispute reported 06/30/2026 896853681
Principal investigator 1 Novo Nordisk AS $22.76 08/11/2022 Non-covered Recipient Entity
HOUSTON CENTER FOR CLINICAL RESEARCH
EX9536-4388 No dispute reported 06/30/2026 896853701
Principal investigator 1 Novo Nordisk AS $22.76 08/11/2022 Non-covered Recipient Entity
HOUSTON CENTER FOR CLINICAL RESEARCH
EX9536-4388 No dispute reported 06/30/2026 896853703
Principal investigator 1 Novo Nordisk AS $11.40 08/11/2022 Non-covered Recipient Entity
HOUSTON CENTER FOR CLINICAL RESEARCH
EX9536-4388 No dispute reported 06/30/2026 896853705
Principal investigator 1 Novo Nordisk AS $22.76 08/11/2022 Non-covered Recipient Entity
HOUSTON CENTER FOR CLINICAL RESEARCH
EX9536-4388 No dispute reported 06/30/2026 896853709
Principal investigator 1 Novo Nordisk AS $11.40 08/11/2022 Non-covered Recipient Entity
HOUSTON CENTER FOR CLINICAL RESEARCH
EX9536-4388 No dispute reported 06/30/2026 896853711
Principal investigator 1 Novo Nordisk AS $22.76 08/11/2022 Non-covered Recipient Entity
HOUSTON CENTER FOR CLINICAL RESEARCH
EX9536-4388 No dispute reported 06/30/2026 896862391
Principal investigator 1 Novo Nordisk AS $22.76 08/11/2022 Non-covered Recipient Entity
HOUSTON CENTER FOR CLINICAL RESEARCH
EX9536-4388 No dispute reported 06/30/2026 896862529
Principal investigator 1 Novo Nordisk AS $22.76 08/11/2022 Non-covered Recipient Entity
HOUSTON CENTER FOR CLINICAL RESEARCH
EX9536-4388 No dispute reported 06/30/2026 896862533
Principal investigator 1 Novo Nordisk AS $22.76 08/11/2022 Non-covered Recipient Entity
HOUSTON CENTER FOR CLINICAL RESEARCH
EX9536-4388 No dispute reported 06/30/2026 896862571
Principal investigator 1 Novo Nordisk AS $22.76 08/11/2022 Non-covered Recipient Entity
HOUSTON CENTER FOR CLINICAL RESEARCH
EX9536-4388 No dispute reported 06/30/2026 896862575
Principal investigator 1 Novo Nordisk AS $22.76 08/11/2022 Non-covered Recipient Entity
HOUSTON CENTER FOR CLINICAL RESEARCH
EX9536-4388 No dispute reported 06/30/2026 896862579
Principal investigator 1 Novo Nordisk AS $22.76 08/11/2022 Non-covered Recipient Entity
HOUSTON CENTER FOR CLINICAL RESEARCH
EX9536-4388 No dispute reported 06/30/2026 896873581
Principal investigator 1 Novo Nordisk AS $11.40 08/11/2022 Non-covered Recipient Entity
HOUSTON CENTER FOR CLINICAL RESEARCH
EX9536-4388 No dispute reported 06/30/2026 896873585
Principal investigator 1 Novo Nordisk AS $11.40 08/11/2022 Non-covered Recipient Entity
HOUSTON CENTER FOR CLINICAL RESEARCH
EX9536-4388 No dispute reported 06/30/2026 896873589
Principal investigator 1 Novo Nordisk AS $22.76 08/11/2022 Non-covered Recipient Entity
HOUSTON CENTER FOR CLINICAL RESEARCH
EX9536-4388 No dispute reported 06/30/2026 896873593
Principal investigator 1 Novo Nordisk AS $11.40 08/11/2022 Non-covered Recipient Entity
HOUSTON CENTER FOR CLINICAL RESEARCH
EX9536-4388 No dispute reported 06/30/2026 896873599
Principal investigator 1 Novo Nordisk AS $13.00 08/11/2022 Non-covered Recipient Entity
HOUSTON CENTER FOR CLINICAL RESEARCH
EX9536-4388 No dispute reported 06/30/2026 896873603
Principal investigator 1 Novo Nordisk AS $13.00 08/11/2022 Non-covered Recipient Entity
HOUSTON CENTER FOR CLINICAL RESEARCH
EX9536-4388 No dispute reported 06/30/2026 896873607
Principal investigator 1 Novo Nordisk AS $13.00 08/11/2022 Non-covered Recipient Entity
HOUSTON CENTER FOR CLINICAL RESEARCH
EX9536-4388 No dispute reported 06/30/2026 896889897
Principal investigator 1 Novo Nordisk AS $11.40 08/11/2022 Non-covered Recipient Entity
HOUSTON CENTER FOR CLINICAL RESEARCH
EX9536-4388 No dispute reported 06/30/2026 896890177
Principal investigator 1 Novo Nordisk AS $11.40 08/11/2022 Non-covered Recipient Entity
HOUSTON CENTER FOR CLINICAL RESEARCH
EX9536-4388 No dispute reported 06/30/2026 896890181
Principal investigator 1 Novo Nordisk AS $11.40 08/11/2022 Non-covered Recipient Entity
HOUSTON CENTER FOR CLINICAL RESEARCH
EX9536-4388 No dispute reported 06/30/2026 896890185
Principal investigator 1 Novo Nordisk AS $22.76 08/11/2022 Non-covered Recipient Entity
HOUSTON CENTER FOR CLINICAL RESEARCH
EX9536-4388 No dispute reported 06/30/2026 896890189
Principal investigator 1 Novo Nordisk AS $22.76 08/11/2022 Non-covered Recipient Entity
HOUSTON CENTER FOR CLINICAL RESEARCH
EX9536-4388 No dispute reported 06/30/2026 896890193
Principal investigator 1 Novo Nordisk AS $22.76 08/11/2022 Non-covered Recipient Entity
HOUSTON CENTER FOR CLINICAL RESEARCH
EX9536-4388 No dispute reported 06/30/2026 896890197
Principal investigator 1 Novo Nordisk AS $22.76 08/11/2022 Non-covered Recipient Entity
HOUSTON CENTER FOR CLINICAL RESEARCH
EX9536-4388 No dispute reported 06/30/2026 896890202
Principal investigator 1 Novo Nordisk AS $11.40 08/11/2022 Non-covered Recipient Entity
HOUSTON CENTER FOR CLINICAL RESEARCH
EX9536-4388 No dispute reported 06/30/2026 896890210
Principal investigator 1 Novo Nordisk AS $11.40 08/11/2022 Non-covered Recipient Entity
HOUSTON CENTER FOR CLINICAL RESEARCH
EX9536-4388 No dispute reported 06/30/2026 896890214
Principal investigator 1 Novo Nordisk AS $11.40 08/11/2022 Non-covered Recipient Entity
HOUSTON CENTER FOR CLINICAL RESEARCH
EX9536-4388 No dispute reported 06/30/2026 896890217
Principal investigator 1 Novo Nordisk AS $11.40 08/11/2022 Non-covered Recipient Entity
HOUSTON CENTER FOR CLINICAL RESEARCH
EX9536-4388 No dispute reported 06/30/2026 896890221
Principal investigator 1 Novo Nordisk AS $13.00 08/11/2022 Non-covered Recipient Entity
HOUSTON CENTER FOR CLINICAL RESEARCH
EX9536-4388 No dispute reported 06/30/2026 896890267
Principal investigator 1 Novo Nordisk AS $13.00 08/11/2022 Non-covered Recipient Entity
HOUSTON CENTER FOR CLINICAL RESEARCH
EX9536-4388 No dispute reported 06/30/2026 896890433
Principal investigator 1 Novo Nordisk AS $22.76 08/11/2022 Non-covered Recipient Entity
HOUSTON CENTER FOR CLINICAL RESEARCH
EX9536-4388 No dispute reported 06/30/2026 896899411
Principal investigator 1 Novo Nordisk AS $11.40 08/11/2022 Non-covered Recipient Entity
HOUSTON CENTER FOR CLINICAL RESEARCH
EX9536-4388 No dispute reported 06/30/2026 896899683
Principal investigator 1 Novo Nordisk AS $11.40 08/11/2022 Non-covered Recipient Entity
HOUSTON CENTER FOR CLINICAL RESEARCH
EX9536-4388 No dispute reported 06/30/2026 896901633
Principal investigator 1 Novo Nordisk AS $11.40 08/11/2022 Non-covered Recipient Entity
HOUSTON CENTER FOR CLINICAL RESEARCH
EX9536-4388 No dispute reported 06/30/2026 896901681
Principal investigator 1 Novo Nordisk AS $11.40 08/11/2022 Non-covered Recipient Entity
HOUSTON CENTER FOR CLINICAL RESEARCH
EX9536-4388 No dispute reported 06/30/2026 896901755
Principal investigator 1 Novo Nordisk AS $11.40 08/11/2022 Non-covered Recipient Entity
HOUSTON CENTER FOR CLINICAL RESEARCH
EX9536-4388 No dispute reported 06/30/2026 896901782
Principal investigator 1 Novo Nordisk AS $22.76 08/11/2022 Non-covered Recipient Entity
HOUSTON CENTER FOR CLINICAL RESEARCH
EX9536-4388 No dispute reported 06/30/2026 896908187
Principal investigator 1 Novo Nordisk AS $11.40 08/11/2022 Non-covered Recipient Entity
HOUSTON CENTER FOR CLINICAL RESEARCH
EX9536-4388 No dispute reported 06/30/2026 896924313
Principal investigator 1 Novo Nordisk AS $11.40 08/11/2022 Non-covered Recipient Entity
HOUSTON CENTER FOR CLINICAL RESEARCH
EX9536-4388 No dispute reported 06/30/2026 896924367
Principal investigator 1 Novo Nordisk AS $11.40 08/11/2022 Non-covered Recipient Entity
HOUSTON CENTER FOR CLINICAL RESEARCH
EX9536-4388 No dispute reported 06/30/2026 896924443
Principal investigator 1 Novo Nordisk AS $11.40 08/11/2022 Non-covered Recipient Entity
HOUSTON CENTER FOR CLINICAL RESEARCH
EX9536-4388 No dispute reported 06/30/2026 896924451
Principal investigator 1 Novo Nordisk AS $22.76 08/11/2022 Non-covered Recipient Entity
HOUSTON CENTER FOR CLINICAL RESEARCH
EX9536-4388 No dispute reported 06/30/2026 896924455
Principal investigator 1 Novo Nordisk AS $11.40 08/11/2022 Non-covered Recipient Entity
HOUSTON CENTER FOR CLINICAL RESEARCH
EX9536-4388 No dispute reported 06/30/2026 896924459
Principal investigator 1 Novo Nordisk AS $21.00 08/11/2022 Non-covered Recipient Entity
HOUSTON CENTER FOR CLINICAL RESEARCH
EX9536-4388 No dispute reported 06/30/2026 896924463
Principal investigator 1 Novo Nordisk AS $13.00 08/11/2022 Non-covered Recipient Entity
HOUSTON CENTER FOR CLINICAL RESEARCH
EX9536-4388 No dispute reported 06/30/2026 896924467
Principal investigator 1 Novo Nordisk AS $13.00 08/11/2022 Non-covered Recipient Entity
HOUSTON CENTER FOR CLINICAL RESEARCH
EX9536-4388 No dispute reported 06/30/2026 896924471
Principal investigator 1 Novo Nordisk AS $11.40 08/11/2022 Non-covered Recipient Entity
HOUSTON CENTER FOR CLINICAL RESEARCH
EX9536-4388 No dispute reported 06/30/2026 896924475
Principal investigator 1 Novo Nordisk AS $11.40 08/11/2022 Non-covered Recipient Entity
HOUSTON CENTER FOR CLINICAL RESEARCH
EX9536-4388 No dispute reported 06/30/2026 896924479
Principal investigator 1 Novo Nordisk AS $22.76 08/11/2022 Non-covered Recipient Entity
HOUSTON CENTER FOR CLINICAL RESEARCH
EX9536-4388 No dispute reported 06/30/2026 896927411
Principal investigator 1 Novo Nordisk AS $11.40 08/11/2022 Non-covered Recipient Entity
HOUSTON CENTER FOR CLINICAL RESEARCH
EX9536-4388 No dispute reported 06/30/2026 896927575
Principal investigator 1 Novo Nordisk AS $11.40 08/11/2022 Non-covered Recipient Entity
HOUSTON CENTER FOR CLINICAL RESEARCH
EX9536-4388 No dispute reported 06/30/2026 896927581
Principal investigator 1 Novo Nordisk AS $22.76 08/11/2022 Non-covered Recipient Entity
HOUSTON CENTER FOR CLINICAL RESEARCH
EX9536-4388 No dispute reported 06/30/2026 896927867
Principal investigator 1 Novo Nordisk AS $22.76 08/11/2022 Non-covered Recipient Entity
HOUSTON CENTER FOR CLINICAL RESEARCH
EX9536-4388 No dispute reported 06/30/2026 896927876
Principal investigator 1 Novo Nordisk AS $22.76 08/11/2022 Non-covered Recipient Entity
HOUSTON CENTER FOR CLINICAL RESEARCH
EX9536-4388 No dispute reported 06/30/2026 896927881
Principal investigator 1 Novo Nordisk AS $11.40 08/11/2022 Non-covered Recipient Entity
HOUSTON CENTER FOR CLINICAL RESEARCH
EX9536-4388 No dispute reported 06/30/2026 896934193
Principal investigator 1 Novo Nordisk AS $22.76 08/11/2022 Non-covered Recipient Entity
HOUSTON CENTER FOR CLINICAL RESEARCH
EX9536-4388 No dispute reported 06/30/2026 896934197
Principal investigator 1 Novo Nordisk AS $22.76 08/11/2022 Non-covered Recipient Entity
HOUSTON CENTER FOR CLINICAL RESEARCH
EX9536-4388 No dispute reported 06/30/2026 896934201
Principal investigator 1 Novo Nordisk AS $11.40 08/11/2022 Non-covered Recipient Entity
HOUSTON CENTER FOR CLINICAL RESEARCH
EX9536-4388 No dispute reported 06/30/2026 896934205
Principal investigator 1 Novo Nordisk AS $11.40 08/11/2022 Non-covered Recipient Entity
HOUSTON CENTER FOR CLINICAL RESEARCH
EX9536-4388 No dispute reported 06/30/2026 896934209
Principal investigator 1 Novo Nordisk AS $13.00 08/11/2022 Non-covered Recipient Entity
HOUSTON CENTER FOR CLINICAL RESEARCH
EX9536-4388 No dispute reported 06/30/2026 896934213
Principal investigator 1 Novo Nordisk AS $13.00 08/11/2022 Non-covered Recipient Entity
HOUSTON CENTER FOR CLINICAL RESEARCH
EX9536-4388 No dispute reported 06/30/2026 896934217
Principal investigator 1 Novo Nordisk AS $22.76 08/11/2022 Non-covered Recipient Entity
HOUSTON CENTER FOR CLINICAL RESEARCH
EX9536-4388 No dispute reported 06/30/2026 896934597
Principal investigator 1 Novo Nordisk AS $10.00 08/11/2022 Non-covered Recipient Entity
HOUSTON CENTER FOR CLINICAL RESEARCH
EX9536-4388 No dispute reported 06/30/2026 896934601
Principal investigator 1 Novo Nordisk AS $11.40 08/11/2022 Non-covered Recipient Entity
HOUSTON CENTER FOR CLINICAL RESEARCH
EX9536-4388 No dispute reported 06/30/2026 896934607
Principal investigator 1 Novo Nordisk AS $11.40 08/11/2022 Non-covered Recipient Entity
HOUSTON CENTER FOR CLINICAL RESEARCH
EX9536-4388 No dispute reported 06/30/2026 896934611
Principal investigator 1 Novo Nordisk AS $22.76 08/11/2022 Non-covered Recipient Entity
HOUSTON CENTER FOR CLINICAL RESEARCH
EX9536-4388 No dispute reported 06/30/2026 896934615
Principal investigator 1 Novo Nordisk AS $11.40 08/11/2022 Non-covered Recipient Entity
HOUSTON CENTER FOR CLINICAL RESEARCH
EX9536-4388 No dispute reported 06/30/2026 896934619
Principal investigator 1 Novo Nordisk AS $13.00 08/11/2022 Non-covered Recipient Entity
HOUSTON CENTER FOR CLINICAL RESEARCH
EX9536-4388 No dispute reported 06/30/2026 896934833
Principal investigator 1 Novo Nordisk AS $11.40 08/11/2022 Non-covered Recipient Entity
HOUSTON CENTER FOR CLINICAL RESEARCH
EX9536-4388 No dispute reported 06/30/2026 896934837
Principal investigator 1 Novo Nordisk AS $11.40 08/11/2022 Non-covered Recipient Entity
HOUSTON CENTER FOR CLINICAL RESEARCH
EX9536-4388 No dispute reported 06/30/2026 896934841
Principal investigator 1 Novo Nordisk AS $11.40 08/11/2022 Non-covered Recipient Entity
HOUSTON CENTER FOR CLINICAL RESEARCH
EX9536-4388 No dispute reported 06/30/2026 896934845
Principal investigator 1 Novo Nordisk AS $22.76 08/11/2022 Non-covered Recipient Entity
HOUSTON CENTER FOR CLINICAL RESEARCH
EX9536-4388 No dispute reported 06/30/2026 896938709
Principal investigator 1 Novo Nordisk AS $11.40 08/11/2022 Non-covered Recipient Entity
HOUSTON CENTER FOR CLINICAL RESEARCH
EX9536-4388 No dispute reported 06/30/2026 896938737
Principal investigator 1 Novo Nordisk AS $11.40 08/11/2022 Non-covered Recipient Entity
HOUSTON CENTER FOR CLINICAL RESEARCH
EX9536-4388 No dispute reported 06/30/2026 896938949
Principal investigator 1 Novo Nordisk AS $11.40 08/11/2022 Non-covered Recipient Entity
HOUSTON CENTER FOR CLINICAL RESEARCH
EX9536-4388 No dispute reported 06/30/2026 896938953
Principal investigator 1 Novo Nordisk AS $11.40 08/11/2022 Non-covered Recipient Entity
HOUSTON CENTER FOR CLINICAL RESEARCH
EX9536-4388 No dispute reported 06/30/2026 896938957
Principal investigator 1 Novo Nordisk AS $22.76 08/11/2022 Non-covered Recipient Entity
HOUSTON CENTER FOR CLINICAL RESEARCH
EX9536-4388 No dispute reported 06/30/2026 896938961
Principal investigator 1 Novo Nordisk AS $22.76 08/11/2022 Non-covered Recipient Entity
HOUSTON CENTER FOR CLINICAL RESEARCH
EX9536-4388 No dispute reported 06/30/2026 896938973
Principal investigator 1 Novo Nordisk AS $11.40 08/11/2022 Non-covered Recipient Entity
HOUSTON CENTER FOR CLINICAL RESEARCH
EX9536-4388 No dispute reported 06/30/2026 896938977
Principal investigator 1 Novo Nordisk AS $11.40 08/11/2022 Non-covered Recipient Entity
HOUSTON CENTER FOR CLINICAL RESEARCH
EX9536-4388 No dispute reported 06/30/2026 896938981
Principal investigator 1 Novo Nordisk AS $22.76 08/11/2022 Non-covered Recipient Entity
HOUSTON CENTER FOR CLINICAL RESEARCH
EX9536-4388 No dispute reported 06/30/2026 896938985
Principal investigator 1 Novo Nordisk AS $13.00 08/11/2022 Non-covered Recipient Entity
HOUSTON CENTER FOR CLINICAL RESEARCH
EX9536-4388 No dispute reported 06/30/2026 896938989
Principal investigator 1 Novo Nordisk AS $11.40 08/11/2022 Non-covered Recipient Entity
HOUSTON CENTER FOR CLINICAL RESEARCH
EX9536-4388 No dispute reported 06/30/2026 896979637
Principal investigator 1 Novo Nordisk AS $11.40 08/11/2022 Non-covered Recipient Entity
HOUSTON CENTER FOR CLINICAL RESEARCH
EX9536-4388 No dispute reported 06/30/2026 896979641
Principal investigator 1 Novo Nordisk AS $22.76 08/11/2022 Non-covered Recipient Entity
HOUSTON CENTER FOR CLINICAL RESEARCH
EX9536-4388 No dispute reported 06/30/2026 896979653
Principal investigator 1 Novo Nordisk AS $22.76 08/11/2022 Non-covered Recipient Entity
HOUSTON CENTER FOR CLINICAL RESEARCH
EX9536-4388 No dispute reported 06/30/2026 896979849
Principal investigator 1 Novo Nordisk AS $22.76 08/11/2022 Non-covered Recipient Entity
HOUSTON CENTER FOR CLINICAL RESEARCH
EX9536-4388 No dispute reported 06/30/2026 896986863
Principal investigator 1 Novo Nordisk AS $11.40 08/11/2022 Non-covered Recipient Entity
HOUSTON CENTER FOR CLINICAL RESEARCH
EX9536-4388 No dispute reported 06/30/2026 896987049
Principal investigator 1 Novo Nordisk AS $22.76 08/11/2022 Non-covered Recipient Entity
HOUSTON CENTER FOR CLINICAL RESEARCH
EX9536-4388 No dispute reported 06/30/2026 896987069
Principal investigator 1 Novo Nordisk AS $22.76 08/11/2022 Non-covered Recipient Entity
HOUSTON CENTER FOR CLINICAL RESEARCH
EX9536-4388 No dispute reported 06/30/2026 896987073
Principal investigator 1 Novo Nordisk AS $22.76 08/11/2022 Non-covered Recipient Entity
HOUSTON CENTER FOR CLINICAL RESEARCH
EX9536-4388 No dispute reported 06/30/2026 897003821
Principal investigator 1 Novo Nordisk AS $11.40 08/11/2022 Non-covered Recipient Entity
HOUSTON CENTER FOR CLINICAL RESEARCH
EX9536-4388 No dispute reported 06/30/2026 897003825
Principal investigator 1 Novo Nordisk AS $22.76 08/11/2022 Non-covered Recipient Entity
HOUSTON CENTER FOR CLINICAL RESEARCH
EX9536-4388 No dispute reported 06/30/2026 897003829
Principal investigator 1 Novo Nordisk AS $11.40 08/11/2022 Non-covered Recipient Entity
HOUSTON CENTER FOR CLINICAL RESEARCH
EX9536-4388 No dispute reported 06/30/2026 897015173
Principal investigator 1 Novo Nordisk AS $22.76 08/11/2022 Non-covered Recipient Entity
HOUSTON CENTER FOR CLINICAL RESEARCH
EX9536-4388 No dispute reported 06/30/2026 897015195
Principal investigator 1 Novo Nordisk AS $22.76 08/11/2022 Non-covered Recipient Entity
HOUSTON CENTER FOR CLINICAL RESEARCH
EX9536-4388 No dispute reported 06/30/2026 897015198
Principal investigator 1 Novo Nordisk AS $22.76 08/11/2022 Non-covered Recipient Entity
HOUSTON CENTER FOR CLINICAL RESEARCH
EX9536-4388 No dispute reported 06/30/2026 897015595
Principal investigator 1 Novo Nordisk AS $22.76 08/11/2022 Non-covered Recipient Entity
HOUSTON CENTER FOR CLINICAL RESEARCH
EX9536-4388 No dispute reported 06/30/2026 897016245
Principal investigator 1 Novo Nordisk AS $11.40 08/11/2022 Non-covered Recipient Entity
HOUSTON CENTER FOR CLINICAL RESEARCH
EX9536-4388 No dispute reported 06/30/2026 897021183
Principal investigator 1 Novo Nordisk AS $22.76 08/11/2022 Non-covered Recipient Entity
HOUSTON CENTER FOR CLINICAL RESEARCH
EX9536-4388 No dispute reported 06/30/2026 897021191
Principal investigator 1 Novo Nordisk AS $22.76 08/11/2022 Non-covered Recipient Entity
HOUSTON CENTER FOR CLINICAL RESEARCH
EX9536-4388 No dispute reported 06/30/2026 897021195
Principal investigator 1 Novo Nordisk AS $22.76 08/11/2022 Non-covered Recipient Entity
HOUSTON CENTER FOR CLINICAL RESEARCH
EX9536-4388 No dispute reported 06/30/2026 897021199
Principal investigator 1 Novo Nordisk AS $1,328.63 07/27/2022 Non-covered Recipient Entity
HOUSTON CENTER FOR CLINICAL RESEARCH
EX9536-4388 No dispute reported 06/30/2026 897016185
Principal investigator 1 ABBVIE INC. $7,324.10 07/05/2022 Non-covered Recipient Entity
HOUSTON CENTER FOR CLINICAL RESEARC
Long-Term Safety Study of Elagolix in Combination With Estradiolx2FNorethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women No dispute reported 06/30/2026 890365489
Principal investigator 1 Novo Nordisk AS $1,238.63 06/29/2022 Non-covered Recipient Entity
HOUSTON CENTER FOR CLINICAL RESEARCH
EX9536-4388 No dispute reported 06/30/2026 896862567
Principal investigator 1 ABBVIE INC. $7,342.13 06/23/2022 Non-covered Recipient Entity
HOUSTON CENTER FOR CLINICAL RESEARC
Long-Term Safety Study of Elagolix in Combination With Estradiolx2FNorethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women No dispute reported 06/30/2026 890363515
Principal investigator 1 ABBVIE INC. $2,640.00 05/11/2022 Non-covered Recipient Entity
HOUSTON CENTER FOR CLINICAL RESEARC
Long-Term Safety Study of Elagolix in Combination With Estradiolx2FNorethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women No dispute reported 06/30/2026 890363499
Principal investigator 1 Novo Nordisk AS $1,238.63 04/29/2022 Non-covered Recipient Entity
HOUSTON CENTER FOR CLINICAL RESEARCH
EX9536-4388 No dispute reported 06/30/2026 896979645
Principal investigator 1 Novo Nordisk AS $1,328.63 03/25/2022 Non-covered Recipient Entity
HOUSTON CENTER FOR CLINICAL RESEARCH
EX9536-4388 No dispute reported 06/30/2026 897003817
Principal investigator 1 ABBVIE INC. $4,952.02 03/17/2022 Non-covered Recipient Entity
HOUSTON CENTER FOR CLINICAL RESEARC
Long-Term Safety Study of Elagolix in Combination With Estradiolx2FNorethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women No dispute reported 06/30/2026 890361131
Principal investigator 1 Novo Nordisk AS $75.00 03/01/2022 Non-covered Recipient Entity
HOUSTON CENTER FOR CLINICAL RESEARCH
EX9536-4388 No dispute reported 06/30/2026 897021187
Principal investigator 1 ABBVIE INC. $1,994.04 02/16/2022 Non-covered Recipient Entity
HOUSTON CENTER FOR CLINICAL RESEARC
Long-Term Safety Study of Elagolix in Combination With Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women No dispute reported 06/30/2026 889777681
Principal investigator 1 Novo Nordisk AS $2,255.63 02/09/2022 Non-covered Recipient Entity
HOUSTON CENTER FOR CLINICAL RESEARCH
EX9536-4388 No dispute reported 06/30/2026 896987259
Principal investigator 1 ABBVIE INC. $7,445.62 01/13/2022 Non-covered Recipient Entity
HOUSTON CENTER FOR CLINICAL RESEARC
Long-Term Safety Study of Elagolix in Combination With Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women No dispute reported 06/30/2026 889773895
Principal investigator 1 Novo Nordisk AS $4.27 01/11/2022 Non-covered Recipient Entity
HOUSTON CENTER FOR CLINICAL RESEARCH
EX9536-4388 No dispute reported 06/30/2026 897015177